Abivax (AAVXF) Shares Outstanding (Weighted Average) (2021 - 2025)

Abivax has reported Shares Outstanding (Weighted Average) over the past 5 years, most recently at $913774.2 for Q4 2025.

  • Quarterly results put Shares Outstanding (Weighted Average) at $913774.2 for Q4 2025, up 35.09% from a year ago — trailing twelve months through Dec 2025 was $913774.2 (up 35.09% YoY), and the annual figure for FY2025 was $886901.8, up 29.45%.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $913774.2 at Abivax, up from $676420.9 in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for AAVXF hit a ceiling of $17.7 million in Q4 2021 and a floor of $227515.2 in Q4 2022.
  • Median Shares Outstanding (Weighted Average) over the past 5 years was $676766.2 (2023), compared with a mean of $4.0 million.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): tumbled 98.71% in 2022 and later soared 197.46% in 2023.
  • Abivax's Shares Outstanding (Weighted Average) stood at $17.7 million in 2021, then tumbled by 98.71% to $227515.2 in 2022, then soared by 197.46% to $676766.2 in 2023, then fell by 0.05% to $676420.9 in 2024, then soared by 35.09% to $913774.2 in 2025.
  • The last three reported values for Shares Outstanding (Weighted Average) were $913774.2 (Q4 2025), $676420.9 (Q4 2024), and $676766.2 (Q4 2023) per Business Quant data.